nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bendamustine plus rituximab in MALT lymphoma
|
Ferreri, Andrés J M |
|
2014 |
1 |
3 |
p. e88-e89 nvt p. |
artikel |
2 |
Blood transfusion: optimising resources
|
The Lancet Haematology, |
|
2014 |
1 |
3 |
p. e85- 1 p. |
artikel |
3 |
First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial
|
Salar, Antonio |
|
2014 |
1 |
3 |
p. e104-e111 nvt p. |
artikel |
4 |
Nitric oxide-based treatment for sickle cell leg ulcers?
|
Steinberg, Martin H |
|
2014 |
1 |
3 |
p. e86-e87 nvt p. |
artikel |
5 |
Post-transplant therapy in multiple myeloma: a hung jury?
|
Kumar, Shaji |
|
2014 |
1 |
3 |
p. e90-e91 nvt p. |
artikel |
6 |
Rethinking ferritin cutoffs for iron deficiency and overload
|
Garcia-Casal, Maria Nieves |
|
2014 |
1 |
3 |
p. e92-e94 nvt p. |
artikel |
7 |
Thalidomide and prednisolone versus prednisolone alone as consolidation therapy after autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the ALLG MM6 multicentre, open-label, randomised phase 3 study
|
Kalff, Anna |
|
2014 |
1 |
3 |
p. e112-e119 nvt p. |
artikel |
8 |
Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trial
|
Minniti, Caterina P |
|
2014 |
1 |
3 |
p. e95-e103 nvt p. |
artikel |